Literature DB >> 17986281

Up-regulation of SOX9 in human sex-determining region on the Y chromosome (SRY)-negative XX males.

Yoshiyuki Kojima1, Yutaro Hayashi, Kentaro Mizuno, Shoichi Sasaki, Yuko Fukui, Peter Koopman, Ken-Ichiro Morohashi, Kenjiro Kohri.   

Abstract

BACKGROUND: In mammals, gonadal sex is normally determined by the presence or absence of the Y chromosome gene SRY. After expression of SRY in the sexually indifferent gonad, a number of genes encoding transcription factors and growth factors implicated in testis differentiation start to show male-specific expression. However, in XX males, these genes must be up-regulated in the absence of SRY, but the aetiology of SRY-negative XX maleness remains unclear. AIM AND METHODS: We examined the expression of representative gonad marker genes in SRY-negative XX male testes.
RESULTS: RT-PCR and immunohistochemical studies revealed that SOX9, DAX-1, Ad4BP/SF-1, WT-1, GATA-4 and MIS were expressed in testicular tissues of SRY-negative XX males. Expression levels of SOX9 in testes of these patients averaged 1.9-fold higher than in normal XY testes, while expression levels of Ad4BP/SF-1, DAX-1 and MIS were lower in the SRY-negative XX testes than in XY testes. All XX patients were found to carry two copies of the SOX9 gene per diploid genome as do normal XX females and XY males. The XX male patients also carried two copies of the DAX-1 gene as do normal XX females, while normal XY males carry a single DAX-1 gene.
CONCLUSIONS: Our data suggest that lesions affecting SOX9 expression are the key factor in sex determination in SRY-negative XX males, and that the decreased expression of Ad4BP/SF-1, DAX-1 and MIS contribute to their clinical features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986281     DOI: 10.1111/j.1365-2265.2007.03101.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  The mechanism of ascorbic acid-induced differentiation of ATDC5 chondrogenic cells.

Authors:  Tecla M Temu; Ke-Ying Wu; Philip A Gruppuso; Chanika Phornphutkul
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-08       Impact factor: 4.310

2.  Characterization and functionality of proliferative human Sertoli cells.

Authors:  Kitty Chui; Alpa Trivedi; C Yan Cheng; Diana B Cherbavaz; Paul F Dazin; Ai Lam Thu Huynh; James B Mitchell; Gabriel A Rabinovich; Linda J Noble-Haeusslein; Constance M John
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

Review 3.  The battle of the sexes for stroke therapy: female- versus male-derived stem cells.

Authors:  Yuji Kaneko; Travis Dailey; Nathan L Weinbren; Jessica Rizzi; Cyrus Tamboli; Julie G Allickson; Nicole Kuzmin-Nichols; Paul R Sanberg; David J Eve; Naoki Tajiri; Cesar V Borlongan
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

4.  All males do not have 46 xy karyotype: A rare case report.

Authors:  Ritesh Kumar Agrawala; Arun Kumar Choudhury; Binoy Kumar Mohanty; Anoj Kumar Baliarsinha
Journal:  Indian J Endocrinol Metab       Date:  2013-10

5.  Molecular cytogenetic analysis and genetic counseling: a case report of eight 46,XX males and a literature review.

Authors:  Fagui Yue; Hongguo Zhang; Qi Xi; Yuting Jiang; Leilei Li; Ruizhi Liu; Ruixue Wang
Journal:  Mol Cytogenet       Date:  2019-11-04       Impact factor: 2.009

Review 6.  46 XX karyotype during male fertility evaluation; case series and literature review.

Authors:  Ahmad Majzoub; Mohamed Arafa; Christopher Starks; Haitham Elbardisi; Sami Al Said; Edmund Sabanegh
Journal:  Asian J Androl       Date:  2017 Mar-Apr       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.